{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:34:21Z","timestamp":1790274861904,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01-NS041588"],"award-info":[{"award-number":["U01-NS041588"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute for Nursing Research","doi-asserted-by":"crossref","award":["R01-NR012726"],"award-info":[{"award-number":["R01-NR012726"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1-RR025777"],"award-info":[{"award-number":["UL1-RR025777"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["T32-HS013852"],"award-info":[{"award-number":["T32-HS013852"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>Epidemiologic and experimental evidence suggests that individuals with diabetes are at increased risk of infection. We sought to examine the association of diabetes and insulin therapy with hospitalization for infection and 28-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>We performed a prospective cohort study using data from 30 239 community-dwelling participants aged \u226545 years enrolled in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. We defined diabetes as a fasting glucose level \u2265126 mg\/L (or \u2265200 mg\/L for those not fasting), the use of insulin or oral hypoglycemic agents, or self-reported history. We identified infection-related hospitalizations over the years 2003\u20132012. We fit Cox proportional hazards models to assess the association of diabetes with hazard rates of infection and logistic regression models for 28-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Among 29 683 patients from the REGARDS study with complete follow-up, 7375 had diabetes. Over a median follow-up period of 6.5 years, we identified 2593 first and 3411 total infection hospitalizations. In adjusted analyses, participants with diabetes had an increased hazard of infection (hazard ratio, 1.50; 95% confidence interval [CI], 1.37\u20131.64) compared with those without diabetes. Participants with diabetes hospitalized for infection did not have an increased odds of death within 28 days (odds ratio, 0.94; 95% CI, .67\u20131.32). Participants receiving insulin therapy had greater hazard of infection (hazard ratio, 2.18; 95% CI, 1.90\u20132.51) but no increased odds of mortality (odd ratio, 1.07; 95% CI, .67\u20131.71).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>Diabetes is associated with increased risk of hospitalization for infection. However, we did not find an association with 28-day mortality. Insulin therapy conferred an even greater risk of hospitalization, without increased mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciw738","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T04:05:52Z","timestamp":1479528352000},"page":"435-442","source":"Crossref","is-referenced-by-count":21,"title":["Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk"],"prefix":"10.1093","volume":"64","author":[{"given":"John P.","family":"Donnelly","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine 1"},{"name":"Division of Preventive Medicine, Department of Medicine 2"},{"name":"Department of Epidemiology 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Safford","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham 5"},{"name":"Department of Medicine, Weill Cornell Medical College 9 , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Center for Vascular Biology Research, Beth Israel Deaconess Medical Center 7"},{"name":"Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School 8 , Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,4]]},"reference":[{"key":"2024111411402264700_CIT0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"2024111411402264700_CIT0002","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2337\/dc15-1335","article-title":"Diabetes and prediabetes and risk of hospitalization: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"39","author":"Schneider","year":"2016","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0003","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc10-1185","article-title":"Diabetes and sepsis: preclinical findings and clinical relevance","volume":"34","author":"Schuetz","year":"2011","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"key":"2024111411402264700_CIT0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-2478(00)00255-8","article-title":"Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology","volume":"74","author":"Llorente","year":"2000","journal-title":"Immunol Lett"},{"key":"2024111411402264700_CIT0006","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diab.39.3.271","article-title":"Handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans","volume":"39","author":"Hostetter","year":"1990","journal-title":"Diabetes"},{"key":"2024111411402264700_CIT0007","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"2024111411402264700_CIT0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200506040-00003","article-title":"Manifestations of cutaneous diabetic microangiopathy","volume":"6","author":"Ngo","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"2024111411402264700_CIT0009","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11908-002-0042-y","article-title":"Lower genital tract infections in diabetic women","volume":"4","author":"Donders","year":"2002","journal-title":"Curr Infect Dis Rep"},{"key":"2024111411402264700_CIT0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/dc06-1469","article-title":"Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis","volume":"30","author":"Ray","year":"2007","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0011","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1185\/03007990802706289","article-title":"Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls","volume":"25","author":"Zhao","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2024111411402264700_CIT0012","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.aje.a000181","article-title":"Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women","volume":"161","author":"Boyko","year":"2005","journal-title":"Am J Epidemiol"},{"key":"2024111411402264700_CIT0013","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","article-title":"Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome","volume":"50","author":"Benfield","year":"2007","journal-title":"Diabetologia"},{"key":"2024111411402264700_CIT0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"2024111411402264700_CIT0016","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1378\/chest.128.5.3233","article-title":"Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus","volume":"128","author":"Falguera","year":"2005","journal-title":"Chest"},{"key":"2024111411402264700_CIT0017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1086\/427699","article-title":"Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults","volume":"40","author":"Thomsen","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2024111411402264700_CIT0018","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0019","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diacare.28.4.810","article-title":"The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia","volume":"28","author":"McAlister","year":"2005","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2007.01.004","article-title":"Impact of diabetes on mortality among patients with community-acquired bacteremia","volume":"55","author":"Tsai","year":"2007","journal-title":"J Infect"},{"key":"2024111411402264700_CIT0021","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/cc8866","article-title":"Insulin-treated diabetes is not associated with increased mortality in critically ill patients","volume":"14","author":"Vincent","year":"2010","journal-title":"Crit Care"},{"key":"2024111411402264700_CIT0022","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/CCM.0b013e3181c02726","article-title":"Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis","volume":"38","author":"Stegenga","year":"2010","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0023","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/cc7717","article-title":"The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study","volume":"13","author":"Esper","year":"2009","journal-title":"Crit Care"},{"key":"2024111411402264700_CIT0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2337\/diacare.27.1.70","article-title":"Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study","volume":"27","author":"Thomsen","year":"2004","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CCM.0b013e3181b9eaa5","article-title":"Diabetes mellitus does not adversely affect outcomes from a critical illness","volume":"38","author":"Graham","year":"2010","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0026","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7326\/0003-4819-144-5-200603070-00006","article-title":"A U.S. population-based survey of Staphylococcus aureus colonization","volume":"144","author":"Graham","year":"2006","journal-title":"Ann Intern Med"},{"key":"2024111411402264700_CIT0027","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2337\/diacare.26.8.2483","article-title":"Insulin injection abscesses caused by Mycobacterium chelonae","volume":"26","author":"Finucane","year":"2003","journal-title":"Diabetes Care"},{"key":"2024111411402264700_CIT0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The reasons for geographic and racial differences in stroke study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"key":"2024111411402264700_CIT0029","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"2024111411402264700_CIT0031","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"2024111411402264700_CIT0032","volume-title":"Helping patients who drink too much, a clinician\u2019s guide","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2005"},{"key":"2024111411402264700_CIT0033","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1001\/archinte.162.18.2074","article-title":"Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines","volume":"162","author":"Janssen","year":"2002","journal-title":"Arch Intern Med"},{"key":"2024111411402264700_CIT0034","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0140-6736(10)61271-8","article-title":"Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study","volume":"376","author":"James","year":"2010","journal-title":"Lancet"},{"key":"2024111411402264700_CIT0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: is there a link? a mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"2024111411402264700_CIT0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fsb2fasebj.12.1.57","article-title":"Leptin regulates proinflammatory immune responses","volume":"12","author":"Loffreda","year":"1998","journal-title":"FASEB J"},{"key":"2024111411402264700_CIT0037","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjmed.2012.03.001","article-title":"Initial management of septic patients with hyperglycemia in the noncritical care inpatient setting","volume":"125","author":"Schuetz","year":"2012","journal-title":"Am J Med"},{"key":"2024111411402264700_CIT0038","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1097\/01.CCM.0000189741.44071.25","article-title":"Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations","volume":"33","author":"Whitcomb","year":"2005","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0039","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/00003246-200007000-00001","article-title":"Diabetic patients have a decreased incidence of acute respiratory distress syndrome","volume":"28","author":"Moss","year":"2000","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"2024111411402264700_CIT0041","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1097\/01.CCM.0000248726.75699.B1","article-title":"The effect of obesity on 12-month survival following admission to intensive care: a prospective study","volume":"34","author":"Peake","year":"2006","journal-title":"Crit Care Med"},{"key":"2024111411402264700_CIT0042","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1378\/chest.123.4.1202","article-title":"Impact of body mass index on outcomes following critical care","volume":"123","author":"Tremblay","year":"2003","journal-title":"Chest"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/435\/25418569\/ciw738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/435\/25418569\/ciw738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:52:44Z","timestamp":1731585164000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/4\/435\/2631864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,4]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,12,4]]},"published-print":{"date-parts":[[2017,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw738","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,15]]},"published":{"date-parts":[[2016,12,4]]}}}